Skip navigation
Speakers

Evaluate the Impact of Shifting Reimbursement Models on Patient Access, Outcomes and Overall Oncology Costs

October 3-4, 2019
  • Scottsdale, AZ

Nick Calla
Vice President, Pharma Relations
BioMatrix Specialty Pharmacy

Anthony V. Coletta, MD, MBA
CEO and Chairman of the Board
Tandigm Health a wholly owned subsidiary of Independence Blue Cross

David Frederiksen
CEO & Founder
PatientFocus

Lance Grady
Managing Director, Commercialization and Market Access
Avalere

Jonathan Harding, MD
Senior Medical Director, Senior Products Division
Tufts Health Plan

Anne Hubbard, MBA
Director of Health Policy
The American Society for Radiation Oncology

Terrill Jordan
President, CEO and Board Member
Regional Care Cancer Associates, LLC

Arif H. Kamal, MD, MBA, MHS, FASCO
Associate Professor of Medicine and Business Administration
Duke University

Aaron Lyss
Director, Strategy and Business Development
Tennessee Oncology

Steven Peskin
Executive Medical Director, Population Health
Horizon Blue Cross Blue Shield of New Jersey

Jeremy Powell
CEO
Acclivity Health Solutions

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Director, Pharmacy Cancer Care, Assistant Professor of Pharmacy
Mayo Clinic

Stella Stergiopoulos
Associate Director, Health Economic Outcomes Research and Payer Policy
Foundation Medicine, Inc.

Nick Calla
Vice President, Pharma Relations
BioMatrix Specialty Pharmacy

Anthony V. Coletta, MD, MBA
CEO and Chairman of the Board
Tandigm Health a wholly owned subsidiary of Independence Blue Cross

David Frederiksen
CEO & Founder
PatientFocus

Lance Grady
Managing Director, Commercialization and Market Access
Avalere

Jonathan Harding, MD
Senior Medical Director, Senior Products Division
Tufts Health Plan

Anne Hubbard, MBA
Director of Health Policy
The American Society for Radiation Oncology

Terrill Jordan
President, CEO and Board Member
Regional Care Cancer Associates, LLC

Arif H. Kamal, MD, MBA, MHS, FASCO
Associate Professor of Medicine and Business Administration
Duke University

Aaron Lyss
Director, Strategy and Business Development
Tennessee Oncology

Steven Peskin
Executive Medical Director, Population Health
Horizon Blue Cross Blue Shield of New Jersey

Jeremy Powell
CEO
Acclivity Health Solutions

Scott Soefje, PharmD, MBA, BCOP, FCCP, FHOPA
Director, Pharmacy Cancer Care, Assistant Professor of Pharmacy
Mayo Clinic

Stella Stergiopoulos
Associate Director, Health Economic Outcomes Research and Payer Policy
Foundation Medicine, Inc.